Literature DB >> 15476282

Adult glioma incidence trends in the United States, 1977-2000.

Kenneth R Hess1, Kristine R Broglio, Melissa L Bondy.   

Abstract

BACKGROUND: Several authors have reported an increase in the incidence of brain tumors, especially among the elderly. A more complete understanding of adult glioma incidence trends might provide indications of risk factors for gliomas and contribute to the search for improved therapies.
METHODS: The authors used the Surveillance, Epidemiology, and End Results (SEER) registry public use data tapes, which included data on patients with cancer diagnosed between 1973 and 2000. For 3 histologies as well as for 12 histology categories combined, the authors used Poisson regression to model incidence as a function of year of diagnosis, age at diagnosis, race (white or African American), and gender. They used cubic splines to fit age at diagnosis and year of diagnosis and tested for all pair-wise interactions.
RESULTS: The interaction between year of diagnosis and age at diagnosis was significant in all four groups modeled. In glioblastoma, there was also a significant interaction between gender and age at diagnosis. In anaplastic astrocytoma, there was a significant interaction between gender and year of diagnosis. In oligodendroglioma, there was a significant interaction between race and gender. In the 12 histology categories combined, there was a significant interaction between gender and age at diagnosis.
CONCLUSIONS: The results in the current study were consistent with other published reports that showed an increase in the incidence of brain tumors using SEER data. Although others have observed increasing incidence trends among the elderly, the authors formally tested and found a statistically significant interaction between age at diagnosis and year of diagnosis. (c) 2004 American Cancer Society

Entities:  

Mesh:

Year:  2004        PMID: 15476282     DOI: 10.1002/cncr.20621

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  103 in total

Review 1.  Pathway inhibition: emerging molecular targets for treating glioblastoma.

Authors:  Wolfgang Wick; Michael Weller; Markus Weiler; Tracy Batchelor; Alfred W K Yung; Michael Platten
Journal:  Neuro Oncol       Date:  2011-06       Impact factor: 12.300

Review 2.  Glycosylation alterations in lung and brain cancer.

Authors:  Hassan Lemjabbar-Alaoui; Andrew McKinney; Yi-Wei Yang; Vy M Tran; Joanna J Phillips
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

3.  Racial/ethnic differences in survival among elderly patients with a primary glioblastoma.

Authors:  Jill S Barnholtz-Sloan; John L Maldonado; Vonetta L Williams; William T Curry; Elizabeth A Rodkey; Frederick G Barker; Andrew E Sloan
Journal:  J Neurooncol       Date:  2007-05-26       Impact factor: 4.130

4.  Over-expression of ARHI decreases tumor growth, migration, and invasion in human glioma.

Authors:  Jing Chen; Songsheng Shi; Weizhong Yang; Chunmei Chen
Journal:  Med Oncol       Date:  2014-01-24       Impact factor: 3.064

5.  Combined c-Met/Trk Inhibition Overcomes Resistance to CDK4/6 Inhibitors in Glioblastoma.

Authors:  Inan Olmez; Ying Zhang; Laryssa Manigat; Mouadh Benamar; Breanna Brenneman; Ichiro Nakano; Jakub Godlewski; Agnieszka Bronisz; Jeongwu Lee; Tarek Abbas; Roger Abounader; Benjamin Purow
Journal:  Cancer Res       Date:  2018-05-29       Impact factor: 12.701

6.  Short-course radiotherapy in elderly patients with glioblastoma: feasibility and efficacy of results from a single centre.

Authors:  L Fariselli; V Pinzi; I Milanesi; A Silvani; M Marchetti; M Farinotti; A Salmaggi
Journal:  Strahlenther Onkol       Date:  2013-04-28       Impact factor: 3.621

7.  Combined imaging biomarkers for therapy evaluation in glioblastoma multiforme: correlating sodium MRI and F-18 FLT PET on a voxel-wise basis.

Authors:  Charles M Laymon; Matthew J Oborski; Vincent K Lee; Denise K Davis; Erik C Wiener; Frank S Lieberman; Fernando E Boada; James M Mountz
Journal:  Magn Reson Imaging       Date:  2012-07-21       Impact factor: 2.546

Review 8.  The spectrum of vaccine therapies for patients with glioblastoma multiforme.

Authors:  Laura K Aguilar; Mariel Arvizu; Estuardo Aguilar-Cordova; E Antonio Chiocca
Journal:  Curr Treat Options Oncol       Date:  2012-12

Review 9.  Brain tumor stem cells as therapeutic targets in models of glioma.

Authors:  Dan Richard Laks; Koppany Visnyei; Harley Ian Kornblum
Journal:  Yonsei Med J       Date:  2010-09       Impact factor: 2.759

Review 10.  Experience with irinotecan for the treatment of malignant glioma.

Authors:  James J Vredenburgh; Annick Desjardins; David A Reardon; Henry S Friedman
Journal:  Neuro Oncol       Date:  2008-09-10       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.